| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |